Co-inhibition of TGF-β and PD-1/PD-L1 signalling has been shown to facilitate T cell penetration into tumours [27,30], suggesting that dual inhibition may overcome resistance [30,31,32]. The gene discussed is TGFB1; the disease is neoplasm.